Top 10 shareholders as of June 30, 2022
| Name |
Number of shares |
Ownership in pct |
| Redmile Group, LLC |
5 380 863 |
12.1% |
| Fjärde AP-Fonden (AP 4) |
2 207 397 |
4.9% |
| Nexttobe AB |
2 155 379 |
4.8% |
| Invesco Advisers, Inc. |
1 973 931 |
4.4% |
| Olausson, Thomas |
1 820 500 |
4.1% |
| Försäkrings AB Avanza Pension |
1 743 201 |
4.0% |
| Tredje AP-Fonden (AP 3) |
1 389 650 |
3.1% |
| The Vanguard Group, Inc. |
1 223 839 |
2.7% |
| Schroder Investment Management, LTD |
888 132 |
2.0% |
| C WorldWide Asset Management |
799 749 |
1.8% |
| Others |
25 005 477 |
56.1% |
| Outstanding shares in total |
44,588,118 |
100.0% |
Source: IHS Markit/IPREO compiled and processed data from various sources, including Euroclear, Morningstar, Factset
and the Swedish Financial Supervisory Authority (Finansinspektionen).
Hansa Biopharma had approximately 18,000 shareholders as of March 31, 2022.
